5 documents found, page 1 of 1
Comorbidities in Patients with Psoriasis: Revisiting the Old Ones, Recognizing ...
Ponte, Pedro.; .
Postirradiation Multiple Minute Digitate Porokeratosis: Case Report
Tavares Bello, Rui; Ponte, Pedro; Vale, EsmeraldaA spectrum of skin conditions – inflammatory, preneoplastic and neoplastic in nature – have been reported to occur as late side effects of radiation therapy. Postiradiation multiple minute digitate porokeratosis (PIMMDP), although seldom reported, has emerged as a distinctively unique variant among porokeratoses. The case of a 47-year-old Caucasianwoman who developed multiple filiform spiny papules mainly over ...
Management of Moderate to Severe Atopic Dermatitis in Adults
Ponte, PedroAtopic dermatitis is a chronic inflammatory skin condition characterized by relapsing pruritic, scaly, erythematous papules and plaques frequently associated with superinfection. It is one of the most common skin diseases affecting 10%-20% of children and 1%-3% of adults, and it is a significant cause of morbidity, quality-of-life impairment and health-care costs. Although many patients can be treated satisfact...
Desenvolvimento e comunicação estratégica de marcas de moda sustentável: um exe...
Araújo, Mariana; Ponte, Pedro; Mota-Ribeiro, Silvana; Broega, A. C.Um ponto importante para o sucesso de uma marca é a sua comunicação, é através dela que as marcas se tornam conhecidas do seu público, nomeadamente, as marcas de moda sustentável. Este artigo tem como objetivo fazer uma reflexão e planeamento sobre o desenvolvimento e a comunicação de marcas de moda sustentável, que neste caso, será aplicada a uma marca recém criada e concebida segundo os princípios da sustenta...
OFF-LABEL USE OF BIOLOGIC AGENTS IN DERMATOLGY – 5-YEAR CLINICAL EXPERIENCE
Diamantino, Filipa; Lestre, Sara; Ponte, Pedro; Ferreira, Ana; Fidalgo, Ana; Lopes, Maria JoãoIntroduction: In recent years, the development of numerous biologic agents extended the therapeutic armamentarium available to dermatologists. Although they are currently approved only for psoriasis, experience is being accumulated with its use in the treatment of different inflammatory skin diseases.Methods: This was a retrospective study of all patients treated in our department with biologic agents for skin ...